Top 10 Performing Stocks To Watch For 2019

Interest rates are surging and stocks like J.P. Morgan Chase and Goldman Sachs would make great additions to a portfolio in times like these, if history is any indication.

Shares of J.P. Morgan surge an average of 5.2 percent over a one-month span when rates are rising sharply, while Goldman’s stock averages a gain of 3.9 percent in such instances. Banks usually benefit from higher rates as they make loans more profitable.

DowDuPont, Exxon Mobil and Visa are also among the best-performing stocks in this environment. When rates move sharply higher, DowDuPont and Exxon Mobil both average gains of 3.5 percent, while Visa posts averages a rise of 3.4 percent.

CNBC used analytics tool Kensho to determine the best-performing stocks in the Dow Jones Industrial Average when the 10-year Treasury note yield rises 25 basis points or more over a span of 30 days. There have been 18 instances of such a move happening since 2008. Last week alone, the 10-year yield rose more than 15 basis points.

Top 10 Performing Stocks To Watch For 2019: Portland General Electric Company(POR)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine upgraded shares of Portland General Electric (NYSE:POR) from a sell rating to a hold rating in a report issued on Friday.

    Several other equities research analysts also recently commented on POR. Guggenheim reiterated a hold rating and set a $40.00 target price on shares of Portland General Electric in a research report on Friday, February 23rd. Bank of America downgraded shares of Portland General Electric from a neutral rating to an underperform rating and cut their target price for the stock from $41.00 to $39.00 in a research report on Tuesday, March 6th. JPMorgan Chase & Co. cut their target price on shares of Portland General Electric from $42.00 to $41.00 and set a neutral rating on the stock in a research report on Tuesday, March 27th. Finally, Zacks Investment Research upgraded shares of Portland General Electric from a sell rating to a hold rating in a research report on Wednesday, May 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $42.44.

  • [By Shane Hupp]

    Sky Solar (NYSE: POR) and Portland General Electric (NYSE:POR) are both utilities companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.

  • [By Max Byerly]

    Opus Investment Management Inc. lowered its holdings in Portland General Electric (NYSE:POR) by 8.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 95,200 shares of the utilities provider’s stock after selling 8,400 shares during the quarter. Opus Investment Management Inc. owned about 0.11% of Portland General Electric worth $3,857,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Massachusetts Financial Services Co. MA grew its stake in shares of Portland General Electric (NYSE:POR) by 16.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 646,219 shares of the utilities provider’s stock after buying an additional 93,580 shares during the period. Massachusetts Financial Services Co. MA owned 0.72% of Portland General Electric worth $27,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Performing Stocks To Watch For 2019: Envestnet, Inc(ENV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Envestnet Inc (NYSE:ENV) insider Shelly O’brien sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, June 4th. The stock was sold at an average price of $54.23, for a total value of $216,920.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Stephan Byrd]

    Zillow (NASDAQ: ZG) and Envestnet (NYSE:ENV) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

  • [By Joseph Griffin]

    MoneyOnMobile (NYSE: ENV) and Envestnet (NYSE:ENV) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership.

  • [By Ethan Ryder]

    Total System Services (NYSE: ENV) and Envestnet (NYSE:ENV) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Envestnet (ENV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in shares of CRH Medical Corp (NYSEAMERICAN:CRHM) by 36.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 867,243 shares of the company’s stock after selling 495,404 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned about 1.19% of CRH Medical worth $3,564,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Watch For 2019: Integrated Electrical Services Inc.(IESC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Gendell Jeffrey L decreased its stake in shares of IES Holdings Inc (NASDAQ:IESC) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,319,064 shares of the technology company’s stock after selling 36,081 shares during the period. IES comprises 21.0% of Gendell Jeffrey L’s portfolio, making the stock its largest holding. Gendell Jeffrey L owned about 0.58% of IES worth $186,634,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Performing Stocks To Watch For 2019: Hollysys Automation Technologies Ltd.(HOLI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been given a consensus rating of “Hold” by the five brokerages that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $25.00.

  • [By Travis Hoium]

    Shares of Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) fell as much as 31.5% in trading Wednesday, after the company reported fiscal fourth-quarter 2018 results. By the time the market closed, some of those gains had been clawed back but were still down 11.1% for the day. 

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Stephan Byrd]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $21.44.

Top 10 Performing Stocks To Watch For 2019: Synchronoss Technologies Inc.(SNCR)

Advisors’ Opinion:

  • [By Timothy Green]

    Shares of Synchronoss Technologies (NASDAQ:SNCR) were suspended from trading on the Nasdaq on Monday due to the company’s failure to satisfy the Nasdaq listing requirements. Synchronoss hasn’t filed a quarterly or annual report with the SEC since February 2017 due to an ongoing financial restatement process. The stock will be quoted on the OTC markets under the same trading symbol during the suspension period. The stock dropped about 7% in pre-market trading.

  • [By Dan Caplinger]

    It’s been a hard road for Synchronoss Technologies (NASDAQ:SNCR). For more than a year, the company worked through restating financials dating back well into the past, and the company found itself having to list its shares on the bulletin boards after the Nasdaq suspended trading in the stock. Nevertheless, through all of its trials and tribulations, Synchronoss has remained steadfast in its determination to emerge from its difficulties stronger than ever. Announcing financial results was a key step toward getting things back to normal.

  • [By Steve Symington]

    Synchronoss Technologies (NASDAQ:SNCR) stock popped 21.6% on Friday after the cloud-based enterprise computing and messaging specialist announced its common shares have been approved for listing on the Nasdaq, which means they’ll resume trading on the widely followed index when the market opens on Monday, October 1, 2018.

  • [By Motley Fool Transcribing]

    Synchronoss Technologies (NASDAQ:SNCR) Q2 2018 Earnings Conference CallAug. 9, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Performing Stocks To Watch For 2019: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    SCS Group (LON:SCS)‘s stock had its “buy” rating reaffirmed by analysts at Peel Hunt in a research note issued to investors on Tuesday.

  • [By Ethan Ryder]

    Peel Hunt reissued their buy rating on shares of SCS Group (LON:SCS) in a research note published on Thursday.

    SCS Group stock opened at GBX 211 ($2.75) on Thursday. SCS Group has a one year low of GBX 127.13 ($1.66) and a one year high of GBX 237 ($3.09).

  • [By Max Byerly]

    SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.

  • [By Ethan Ryder]

    Seaport Global Securities upgraded shares of Steelcase (NYSE:SCS) from a neutral rating to a buy rating in a report published on Friday, Marketbeat Ratings reports. Seaport Global Securities currently has $20.00 price objective on the business services provider’s stock.

Top 10 Performing Stocks To Watch For 2019: SM Energy Company(SM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SM Energy Co (NYSE:SM) gapped up prior to trading on Tuesday . The stock had previously closed at $32.22, but opened at $32.20. SM Energy shares last traded at $31.49, with a volume of 60289 shares trading hands.

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY WARNING: “SM Energy Sees Unusually High Options Volume (SM)” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3353537/sm-energy-sees-unusually-high-options-volume-sm.html.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on SM Energy (SM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Shares of oil producers Laredo Petroleum (NYSE:LPI) and SM Energy (NYSE:SM), as well as units of Golar LNG Partners LP (NASDAQ:GMLP), an MLP that owns liquified natural gas carriers and floating storage and regasification units, all declined by double digits by Friday afternoon. Lower oil prices weighed on the first two, while an analyst downgrade was the culprit in the latter.

  • [By Logan Wallace]

    Scotia Howard Weill upgraded shares of SM Energy (NYSE:SM) from a sector perform rating to a sector outperform rating in a research note published on Thursday morning.

  • [By Joseph Griffin]

    SM Energy (NYSE:SM) had its target price lifted by Citigroup to $29.00 in a report issued on Friday morning, The Fly reports. The brokerage currently has a neutral rating on the energy company’s stock.

Top 10 Performing Stocks To Watch For 2019: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Ethan Ryder]

    Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Coherent (COHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. boosted its position in Coherent, Inc. (NASDAQ:COHR) by 6.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 635,597 shares of the scientific and technical instruments company’s stock after purchasing an additional 41,113 shares during the quarter. Epoch Investment Partners Inc. owned approximately 2.62% of Coherent worth $99,420,000 at the end of the most recent quarter.

  • [By Keith Noonan]

    Coherent, Inc. (NASDAQ:COHR) stock jumped 20.6% in August, according to data provided by S&P Global Market Intelligence. The company published third-quarter results at the end of July that came in below the market’s expectations, but comments during the company’s earnings call appear to have helped the stock regain some ground.

  • [By Logan Wallace]

    Coherent (NASDAQ: COHR) and Integra Lifesciences (NASDAQ:IART) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

  • [By ]

    Coherent, Inc. (NASDAQ:COHR) is one of the oldest companies in the laser technology space based in California, US. The company employs around 5,218 employees and has grown rapidly in terms of revenues as well as profits over the past few years. A recent sell-off as a result of forex risks and a negative market sentiment with respect to lasers has brought the stock price down to reasonable valuations. However, analysts continue to remain bullish on the stock with target prices showing a minimum appreciation of 40% over the current market price.

Leave a Reply

Your email address will not be published. Required fields are marked *